[Cross-sectional imaging of peripheral involvement in psoriatic arthritis].
The purpose of this article is to: 1) describe the main plain film, ultrasound and MR imaging features of peripheral involvement in psoriatic arthritis, 2) describe the advantages of ultrasound and MRI at the early stages of the disease; 3) describe how to use MRI and ultrasound in order to assess response to tumor necrosis factor-alpha blocker therapy.
Denis
A
A
Service de Radiologie Centrale, CHU Purpan, 31059 Toulouse cedex, France. denis_a@chu-toulouse.fr
Lapegue
F
F
Sans
N
N
Vial
J
J
Chiavassa-Gandois
H
H
Fournie
B
B
Railhac
J J
JJ
D000173:Acromioclavicular Joint / Q000473:pathology; D000328:Adult; D018501:Antirheumatic Agents / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D005384:Finger Joint / Q000473:pathology; D005500:Follow-Up Studies; D006621:Hip Joint / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D012785:Shoulder Joint / Q000473:pathology; D013585:Synovitis / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014463:Ultrasonography; D018615:Ultrasonography, Doppler, Color
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha